-
-
Increasing the capacity of U.S. clinicians to provide high quality sexual and reproductive health (SRH) care for all Americans is an urgent public health priority, and proponents are working fast to implement new strategies to meet the need.
-
An experimental levonorgestrel 20 mcg intrauterine device (LNG20 IUD) is under development by Medicines360, a San Francisco-based nonprofit pharmaceutical company.
-
This new evidence-based guidance from the CDC will improve and streamline how we provide contraceptive services to our patients, says Andrew Kaunitz, MD
-
Women over age 40 might underestimate their need for effective birth control; however, despite declining fertility, such women can be at risk for unintended pregnancy.
-
Results of a just-published study indicate a possible method to predict when a woman will have her final menstrual period.1 Such findings might be helpful in aiding women and providers in combatting potential bone loss and cardiovascular risk associated with onset of menopause.
-
In a decision more than 10 years in the making, a U.S. Federal District judge ruled April 5, 2013, that the Food and Drug Administration (FDA) must lift age and point-of-sale restrictions on Plan B One-Step emergency contraception (EC) within 30 days.
-
A new Agency for Healthcare Research and Quality (AHRQ) review of available evidence reveals that women who have problematic irregular or heavy cyclic menstrual bleeding have several safe and effective nonsurgical treatment options.1
-
Add new research to your clinics protocols: The risk of developing pelvic inflammatory disease (PID) following insertion of an intrauterine device (IUD) is very low, whether or not women have been screened beforehand for gonorrhea and chlamydia.
-
Check your clinics patient files for the last year. How many visits were made by males? According to 2010 data from the Agency for Healthcare Research and Quality, just over half of U.S. men (57%) see a doctor, nurse practitioner, or physician assistant for routine care, compared to nearly three-quarters (74%) of women.